Advanced search
Publication Cover
The European Journal of Contraception & Reproductive Health Care Volume 13, 2008 - Issue 3
Submit an article Journal homepage
469
Views
24
CrossRef citations to date
0
Altmetric
Original Research Articles

Effect of the subdermal contraceptive etonogestrel implant (Implanon®) on biochemical and hormonal parameters (three years follow-up)

M. Murat Inal Aegean Obstetrics and Gynaecology Teaching and Research Hospital, Izmir, TurkeyCorrespondence[email protected]
, MD,
Yusuf Yildirim Aegean Obstetrics and Gynaecology Teaching and Research Hospital, Izmir, Turkey
,
Kenan Ertopcu Aegean Obstetrics and Gynaecology Teaching and Research Hospital, Izmir, Turkey
,
M. Eftal Avci Aegean Obstetrics and Gynaecology Teaching and Research Hospital, Izmir, Turkey
,
Isa Ozelmas Aegean Obstetrics and Gynaecology Teaching and Research Hospital, Izmir, Turkey
&
Sivekar Tinar Aegean Obstetrics and Gynaecology Teaching and Research Hospital, Izmir, Turkey
Pages 238-242 | Published online: 06 Jul 2009

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Giovanni Grandi, Pierluigi Di Vinci, Alice Sgandurra, Lia Feliciello, Francesca Monari & Fabio Facchinetti. (2022) Contraception During Perimenopause: Practical Guidance. International Journal of Women's Health 14, pages 913-929.
Read now
Milena B Brito, Rui A Ferriani, Silvana M Quintana, Marcos F Silva de Sá & Carolina S Vieira. (2010) Absence of adverse hepatic or renal effects with the etonogestrel-releasing contraceptive implant inserted immediately postpartum. Open Access Journal of Contraception 1, pages 127-133.
Read now
Heather Hohmann. (2009) Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive. Patient Preference and Adherence 3, pages 205-211.
Read now

Articles from other publishers (21)

Ömer Özcan, Wendy P.J. den Elzen, Jacquelien J. Hillebrand, Martin den Heijer, Laura L. van Loendersloot, Johan Fischer, Henrike Hamer, Robert de Jonge & Annemieke C. Heijboer. (2024) The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review. Clinical Chemistry and Laboratory Medicine (CCLM) 62:1, pages 18-40.
Crossref
. (2022) FSRH Guideline (August 2022) Progestogen-only Pills. BMJ Sexual & Reproductive Health 48:Suppl 1, pages 1-75.
Crossref
Amy J. Voedisch, Rebecca Dunsmoor-Su & Jennifer Kasirsky. (2021) Menopause: A Global Perspective and Clinical Guide for Practice. Clinical Obstetrics & Gynecology 64:3, pages 528-554.
Crossref
Eliza Buyers, Amy E. Sass, Cameron D. Severn, Laura Pyle & Melanie Cree-Green. (2021) Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome. Journal of Pediatric and Adolescent Gynecology 34:1, pages 33-39.
Crossref
Amy J. Voedisch & Danit Ariel. (2020) Perimenopausal contraception. Current Opinion in Obstetrics & Gynecology 32:6, pages 399-407.
Crossref
Elise D. Berlan, Molly J. Richards, Carolina Sales Vieira, Mitchell D. Creinin, Andrew M. Kaunitz, Ian S. Fraser, Alison Edelman & Diana Mansour. (2020) Best Practices for Counseling Adolescents about the Etonogestrel Implant. Journal of Pediatric and Adolescent Gynecology 33:5, pages 448-454.
Crossref
. (2019) FSRH Guideline (April 2019) Overweight, Obesity and Contraception. BMJ Sexual & Reproductive Health 45:Suppl 2, pages 1-69.
Crossref
Taniqua A. Miller, Rebecca H. Allen, Andrew M. KaunitzCarrie A. Cwiak. (2018) Contraception for midlife women: a review. Menopause 25:7, pages 817-827.
Crossref
Katarzyna Kowalska & Halina Milnerowicz. (2016) Pro/antioxidant status in young healthy women using oral contraceptives. Environmental Toxicology and Pharmacology 43, pages 1-6.
Crossref
Jessica W Kiley & Leanne R Griffin. (2015) Contraceptive care after gestational diabetes: considerations for clinical practice. Diabetes Management 5:6, pages 457-472.
Crossref
Jennifer Amico, Bhavik Kumar, Hilary Rosenstein & Marji Gold. (2015) The Contraceptive Implant: An Updated Review of the Evidence. Current Obstetrics and Gynecology Reports 4:1, pages 79-88.
Crossref
Jesus Hernandez-Juarez, Ethel A Garcia-Latorre, Manuel Moreno-Hernandez, Jose Fernando Moran-Perez, Miguel Angel Rodriguez-Escobedo, Gerardo Cogque-Hernandez, Rubén Julián-Nacer, Xochitl Hernandez-Giron, Rosalia Palafox-Gomez, Irma Isordia-Salas & Abraham Majluf-Cruz. (2014) Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study. Reproductive Health 11:1.
Crossref
Meredith Macrae Warden, Jody Steinauer & Elizabeth Harleman. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient 55 68 .
Meredith Macrae Warden, Jody Steinauer & Elizabeth Harleman. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient 55 68 .
Fatemeh Zal, Zohreh Mostafavi-Pour, Fatemeh Amini & Afrooz Heidari. (2012) Effect of vitamin E and C supplements on lipid peroxidation and GSH-dependent antioxidant enzyme status in the blood of women consuming oral contraceptives. Contraception 86:1, pages 62-66.
Crossref
Carolina L. Oderich, Maria Celeste O. Wender, Jaqueline N. Lubianca, Letícia M. Santos & Grasiele C. de Mello. (2012) Impact of etonogestrel-releasing implant and copper intrauterine device on carbohydrate metabolism: a comparative study. Contraception 85:2, pages 173-176.
Crossref
Cristina A.F. Guazzelli, Flaviano Teixeira de Queiroz, Marcia Barbieri, Fernando A. Barreiros, Maria Regina Torloni & Fabio F. Araujo. (2011) Metabolic effects of contraceptive implants in adolescents. Contraception 84:4, pages 409-412.
Crossref
Hang Wun Raymond Li, Ching Yin Grace Wong, William Shu Biu Yeung, Pak Chung Ho & Ernest Hung Yu Ng. (2011) Serum anti-müllerian hormone level is not altered in women using hormonal contraceptives. Contraception 83:6, pages 582-585.
Crossref
Berna Dilbaz, Ozlem Ozdegirmenci, Eray Caliskan, Serdar Dilbaz & Ali Haberal. (2010) Effect of etonogestrel implant on serum lipids, liver function tests and hemoglobin levels. Contraception 81:6, pages 510-514.
Crossref
Monique Hedderson. 2010. Gestational Diabetes During and After Pregnancy. Gestational Diabetes During and After Pregnancy 317 329 .
Lorenzo Arribas-Mir, Dolores Rueda-Lozano, María Agrela-Cardona, Tania Cedeño-Benavides, Carmen Olvera-Porcel & Aurora Bueno-Cavanillas. (2009) Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain. Contraception 80:5, pages 457-462.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.